Author:
Drake Charles G.,Lipson Evan J.,Brahmer Julie R.
Publisher
Springer Science and Business Media LLC
Reference111 articles.
1. Mellman, I., Coukos, G. & Dranoff, G. Cancer immunotherapy comes of age. Nature 480, 480–489 (2011).
2. McDermott, D. F. Immunotherapy of metastatic renal cell carcinoma. Cancer 115, 2298–2305 (2009).
3. Escudier, B. Emerging immunotherapies for renal cell carcinoma. Ann. Oncol. 23 (Suppl. 8), viii35–viii40 (2012).
4. Biswas, S. & Eisen, T. Immunotherapeutic strategies in kidney cancer--when TKIs are not enough. Nat. Rev. Clin. Oncol. 6, 478–487 (2009).
5. Nakano, O. et al. Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity. Cancer Res. 61, 5132–5136 (2001).
Cited by
372 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献